Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Recurrent coronary stent thrombosis

Authors: Gitel’zon D.G., Faibushevich A.G., Gitel’zon E.A., Vasiliev A.E., Danishian K.I.

Company:
1 National Medical Research Center for Hematology, Moscow, Russian Federation
2 Peoples’ Friendship University of Russia, Moscow, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2022-19-3-197-200

UDC: 616.123.3-005.6

Link: Clinical Physiology of Blood Circulaiton. 2022; 3 (19): 197-200

Quote as: Gitel’zon D.G., Faibushevich A.G., Gitel’zon E.A., Vasiliev A.E., Danishian K.I. Recurrent coronary stent thrombosis. Clinical Physiology of Circulation. 2022; 19 (3): 197–200 (in Russ.). DOI: 10.24022/1814-6910-2022-19-3-197-200

Received / Accepted:  21.01.2022 / 10.09.2022

Download
Full text:  

Abstract

The review discusses the problem of recurrent coronary stent thrombosis development. The study of prevalence and search for risk factors of this life-threatening complication continues. Intravascular imaging, thin stent struts and more effective antiplatelet agents significantly reduced the risk of thrombotic complications after coronary artery stenting. Despite the significant progress made in this area, there are still many unresolved issues that need to be addressed in future research.

About Authors

  • Daniel G. Gitel’zon, Cand. Med. Sci., Interventional Radiologist; ORCID
  • Aleksandr G. Faibushevich, Cand. Med. Sci., Chief of Chair; ORCID
  • Ekaterina A. Gitel’zon, Cand. Med. Sci., Assistant Professor; ORCID
  • Aleksandr E. Vasiliev, Cand. Med. Sci.; ORCID
  • Karen I. Danishian, Dr. Med. Sci., Head of Department; ORCID

 If you found mistakes, select text and press Alt+A